As of February 11, 2025, there have been no reports of disturbing news concerning Elijah Hewson, the lead singer of the Irish rock band Inhaler. On the contrary, the band is experiencing a period of significant activity and success.
Inhaler released their third studio album, Open Wide, on February 7, 2025. The album, produced by Grammy Award-winner Kid Harpoon, features 13 tracks and has been described as a “guitar-driven pop album like no other.”
Following the album’s release, Inhaler is set to embark on their most extensive UK tour to date, starting in Leeds on February 7 and concluding in Newcastle on February 19. The tour includes a headline show at London’s iconic Brixton Academy. After the UK leg, the band will continue with a 15-date tour across Europe before heading to Japan in June.
In a recent interview, Elijah Hewson, who turned 25 in August 2024, reflected on the band’s journey and their evolving sound. He emphasized their commitment to carving out their own identity in the music industry, independent of his lineage as the son of U2’s Bono.
The band has also announced a series of North American tour dates in support of Open Wide. The tour will launch in Toronto on February 28 and wrap up in Dallas on March 19, with stops in cities such as Brooklyn, Philadelphia, Austin, and Washington, D.C.
Inhaler’s recent activities highlight a period of growth and success for the band, with no indications of any disturbing news related to Elijah Hewson.